A whale with a lot of money to spend has taken a noticeably bearish stance on Vertex Pharmaceuticals.
Looking at options history for Vertex Pharmaceuticals VRTX we detected 13 strange trades.
If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 69% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $409,890 and 5, calls, for a total amount of $296,161.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $310.0 for Vertex Pharmaceuticals over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Vertex Pharmaceuticals options trades today is 241.89 with a total volume of 700.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Vertex Pharmaceuticals's big money trades within a strike price range of $100.0 to $310.0 over the last 30 days.
Vertex Pharmaceuticals Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| VRTX | CALL | TRADE | BULLISH | 01/19/24 | $100.00 | $100.9K | 12 | 5 |
| VRTX | PUT | TRADE | BULLISH | 12/16/22 | $290.00 | $99.0K | 5 | 150 |
| VRTX | CALL | SWEEP | BULLISH | 01/20/23 | $300.00 | $77.0K | 1.2K | 58 |
| VRTX | CALL | TRADE | BEARISH | 01/20/23 | $100.00 | $57.8K | 29 | 3 |
| VRTX | PUT | TRADE | BEARISH | 12/16/22 | $280.00 | $50.5K | 16 | 52 |
Where Is Vertex Pharmaceuticals Standing Right Now?
- With a volume of 2,186,678, the price of VRTX is down -7.49% at $287.86.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 0 days.
What The Experts Say On Vertex Pharmaceuticals:
- JP Morgan has decided to maintain their Overweight rating on Vertex Pharmaceuticals, which currently sits at a price target of $327.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Vertex Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
